These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Successful Emergency Carotid Endarterectomy after Thrombolysis with Intravenous Recombinant Tissue-Type Plasminogen Activator. Yamamoto Y; Okazaki T; Yoda K; Tada Y; Nagahiro S J Med Invest; 2016; 63(3-4):300-4. PubMed ID: 27644576 [TBL] [Abstract][Full Text] [Related]
23. Local intra-arterial fibrinolysis in acute hemispheric stroke: effect of occlusion type and fibrinolytic agent on recanalization success and neurological outcome. Eckert B; Kucinski T; Neumaier-Probst E; Fiehler J; Röther J; Zeumer H Cerebrovasc Dis; 2003; 15(4):258-63. PubMed ID: 12686789 [TBL] [Abstract][Full Text] [Related]
24. [Intravenous recombinant tissue-type plasminogen activator in acute myocardial infarction]. Gao R Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Aug; 19(4):228-30, 267-8. PubMed ID: 1813288 [TBL] [Abstract][Full Text] [Related]
25. Comparative study of intravenous thrombolysis with rt-PA and urokinase for patients with acute cerebral infarction. Sun F; Liu H; Fu HX; Zhang S; Qian XD; Li JJ; Zhu YB; Zhang XX; Zhang J; Qiu HP; Kang LL; Hu YJ; Zhao L; Mi YJ; Gao YJ; Dou ZJ; Ma Z J Int Med Res; 2020 May; 48(5):300060519895352. PubMed ID: 32357116 [TBL] [Abstract][Full Text] [Related]
26. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators. Smalling RW; Bode C; Kalbfleisch J; Sen S; Limbourg P; Forycki F; Habib G; Feldman R; Hohnloser S; Seals A Circulation; 1995 Jun; 91(11):2725-32. PubMed ID: 7758177 [TBL] [Abstract][Full Text] [Related]
27. Stroke outcomes of Japanese patients with major cerebral artery occlusion in the post-alteplase, pre-MERCI era. Endo K; Koga M; Sakai N; Yamagami H; Furui E; Matsumoto Y; Shiokawa Y; Yoshimura S; Okada Y; Nakagawara J; Hyogo T; Hasegawa Y; Nagashima H; Fujinaka T; Hyodo A; Terada T; Toyoda K; J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):805-10. PubMed ID: 22721823 [TBL] [Abstract][Full Text] [Related]
28. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog. Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779 [TBL] [Abstract][Full Text] [Related]
37. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Levine M; Hirsh J; Weitz J; Cruickshank M; Neemeh J; Turpie AG; Gent M Chest; 1990 Dec; 98(6):1473-9. PubMed ID: 2123152 [TBL] [Abstract][Full Text] [Related]
38. Designing thrombolytic agents: focus on safety and efficacy. Collen D Am J Cardiol; 1992 Jan; 69(2):71A-81A. PubMed ID: 1729881 [TBL] [Abstract][Full Text] [Related]
39. Endovascular treatment in proximal and intracranial carotid occlusion 9 hours after symptom onset. Jakubowska MM; Michels P; Müller-Jensen A; Leppien A; Eckert B Neuroradiology; 2008 Jul; 50(7):599-604. PubMed ID: 18443776 [TBL] [Abstract][Full Text] [Related]
40. [Prospects of thrombolytic therapy for acute ischemic stroke]. Nakashima T; Minematsu K Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]